Update on Bliss GVS Pharma acquisition; corrections to previous disclosure

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF Explain this filing

ANURAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.5%1-day move

₹1183.50

prior close

₹1181.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.3-0.4-0.3-0.2-1.5-1.3-1.6-7.9——————

Up moveDown movePending

AI summary

Anupam Rasayan and PAC Mates Visa Consultancy completed the acquisition of Bliss GVS Pharma shares on 28 Sep 2026. PAC bought 5.09 crore shares (47.95%) under the SPA. Acquirer holds 22.51 lakh shares (22.50 lakh plus 1,669). Combined stake exceeds 50%. Acquisition is pursuant to an open offer. Filing corrects a prior typo from 1,699 to 1,669 shares.

Likely market impact

Anupam Rasayan gains significant control over Bliss GVS Pharma via combined holdings, triggering open offer and consolidation implications.